Alnylam

Analyst Coverage

Firm Analyst Contact Information
Leerink Partners   Paul Matteis E-mail
Phone: (617) 918-4585
Goldman Sachs   Terence Flynn E-mail
Phone: (212) 357-5057
JMP Securities LLC   Mike G. King E-mail
Phone: (212) 906-3520
Needham & Company   Alan Carr E-mail
Phone: (212) 705-0435
Piper Jaffray & Co.   Edward Tenthoff E-mail
Phone: (212) 284-9403
Stifel Nicolaus   Stephen Willey E-mail
Phone: (212) 271-3620
Credit Suisse   Alethia Young E-mail
Phone: (212) 538-0640
Cowen   Ritu Baral E-mail
Phone: (646) 562-1379
Barclays   Gena Wang E-mail
Phone: (212) 526-4252
Barclays   Geoff Meacham E-mail
Phone: (212) 526-2795
J.P. Morgan   Anupam Rama E-mail
Phone: (212) 622-0900
Jefferies   Maury Raycroft E-mail
Phone: (212) 323-3990
Chardan   Gbola Amusa E-mail
Phone: (646) 465-9024
Morgan Stanley   David Lebowitz E-mail
Phone: (212) 761-0324
Bernstein   Vincent Chen E-mail
Phone: (212) 969-6607
BMO Capital Markets   Do Kim E-mail
Phone: (212) 885-4091
Nomura   Christopher Marai E-mail
Phone: (212) 310-5466
FBR Capital Markets & Co.   Madhu Kumar E-mail
Phone: (646) 885-5461

Alnylam Pharmaceuticals, Inc. is followed by the analyst(s) listed above. Please note that any opinions, estimates or forecasts regarding Alnylam Pharmaceuticals, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Alnylam Pharmaceuticals, Inc. or its management. Alnylam Pharmaceuticals, Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.